2024 Third Quarter Financial Results Conference Call

[sla55]

investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2024-third-quarter-financial-results

MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2024 financial results will be released after market close on Thursday, November 7, 2024.

MannKind will host a webcast beginning at 4:30 p.m. Eastern Time to discuss the quarterly results and provide a business update. Participating in the conference call from MannKind will be Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer Chris Prentiss. The webcast will be accessible via a link on MannKind’s website at investors.mannkindcorp.com/events-and-presentations. A replay will also be available in the same location within 24 hours following the call and be accessible for approximately 90 days.

About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.

We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.

With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.

Please visit mannkindcorp.com to learn more, and follow us on LinkedIn, Facebook, X or Instagram.

[prcgorman2]

Earnings call on a Thursday evening. I like it.

[peppy]

I did not see Mike C or the new financial officer mention the convertible bonds. Did I miss it?

finance.yahoo.com/news/mannkind-mnkd-q3-2024-earnings-041518224.html

"Loss on extinguishment of debt of $7.1 million for the nine months ended September 30, 2024 was incurred in connection with the prepayment of the MidCap credit facility and the Mann Group convertible note in April 2024.

Cash, cash equivalents and investments as of September 30, 2024 were $268.4 million."

[letitride]

 I dont believe those bonds are an issue  to Mike. The Icon trial and preparation for a FDA meet 1st half of 2025 on Nintednib and PEDS are probably on que. Those bonds could be completely washed out by 2026 with the benefit of what he may also not be talking about. IMO Lets Go!